Advertisement
Clinical study| Volume 12, ISSUE 4, P409-415, May 2005

Download started.

Ok

Increased circulating T cell reactivity to GM1 ganglioside in patients with Guillain–Barré syndrome

      Summary

      This study was performed to determine whether increased ganglioside-specific T cell reactivity can be detected in the peripheral blood of patients with Guillain–Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). T cell responsiveness to the gangliosides GM1, GM3, GD1a, GD1b, GD3, GT1b, GQ1b and sulphatide was assessed in peripheral blood mononuclear cells from untreated GBS patients (57), CIDP patients (43), patients with other peripheral neuropathies (55) and healthy control subjects (74) in a standard 6-day proliferation assay. Increased T cell reactivity to GM1 occurred in GBS patients compared to healthy controls and patients with other neuropathies. There was increased reactivity to GM3 in GBS patients compared to patients with other neuropathies but not compared to healthy controls. The frequencies of increased T cell reactivity to GM1 and GM3 in CIDP patients were intermediate between those of GBS patients and controls. We suggest that T cell reactivity to gangliosides might play a contributory role in the pathogenesis of GBS and perhaps CIDP.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Clinical Neuroscience
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • van Doorn P.A.
        • Garssen M.P.J.
        Treatment of immune neuropathies.
        Curr Opin Neurol. 2002; 15: 623-631
        • Odaka M.
        • Yuki N.
        • Hirata K.
        Patients with chronic inflammatory demyelinating polyneuropathy initially diagnosed as Guillain–Barré syndrome.
        J Neurol. 2003; 250: 913-916https://doi.org/10.1007/s00415-003-1096-y
        • Hughes R.A.C.
        • Hadden R.D.M.
        • Gregson N.A.
        • Smith K.J.
        Pathogenesis of Guillain–Barré syndrome.
        J Neuroimmunol. 1999; 100: 74-97
        • Schwerer B.
        Antibodies against gangliosides: a link between preceding infection and immunopathogenesis of Guillain–Barré syndrome.
        Microbes Infect. 2002; 4: 373-384
        • Pollard J.D.
        Chronic inflammatory demyelinating polyradiculoneuropathy.
        Curr Opin Neurol. 2002; 15: 279-283
        • Kieseier B.C.
        • Dalakas M.C.
        • Hartung H.
        Immune mechanisms in chronic inflammatory demyelinating neuropathy.
        Neurology. 2002; 59: S7-S12
        • Ariga T.
        • Miyatake T.
        • Yu R.K.
        Recent studies on the roles of antiglycosphingolipids in the pathogenesis of neurological disorders.
        J Neurosci Res. 2001; 65: 363-370
        • Willison H.J.
        • Yuki N.
        Peripheral neuropathies and anti-glycolipid antibodies.
        Brain. 2002; 125: 2591-2625
        • Yu RK
        • Saito M.
        Structure and localization of gangliosides.
        in: Margolis RU Margolis RK Neurobiology of Glycoconjugates. Plenum Press, New York1989: 1-42
        • Kracun I.
        • Rosner H.
        • Cosovic C.
        • Stavljenic A.
        Topographical atlas of the gangliosides of the adult human brain.
        J Neurochem. 1984; 43: 979-989
        • Chiba A.
        • Kusunoki S.
        • Obata H.
        • Machinami R.
        • Kanazawa I.
        Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome.
        Brain Res. 1997; 745: 32-36
        • Kusunoki S.
        • Chiba A.
        • Tai T.
        • Kanazawa I.
        Localization of GM1 and GD1b antigens in the human peripheral nervous system.
        Muscle Nerve. 1993; 16: 752-756
        • Gong Y.
        • Tagawa Y.
        • Lunn M.P.
        • et al.
        Localization of major gangliosides in the PNS: implications for immune neuropathies.
        Brain. 2002; 125: 2491-2506
        • Koga M.
        • Yuki N.
        • Tsukada Y.
        • Hirata K.
        • Matsumoto Y.
        CDR3 spectratyping analysis of the T cell receptor repertoire in Guillan–Barré and Fisher syndromes.
        J Neuroimmunol. 2003; 141: 112-117https://doi.org/10.1016/S0165-5728(03)00212-1
        • Tagawa Y.
        • Yuki N.
        • Hirata K.
        High anti-GM1 and anti-GD1a IgG antibody titers are detected in Guillain–Barré syndrome but not in chronic inflammatory demyelinating polyneuropathy.
        Eur Neurol. 2002; 48: 118-119
        • Asbury A.K.
        Diagnostic considerations in Guillain–Barré.
        Ann Neurol. 1981; 9: 1-5
        • Dyck P.J.
        • Lais A.C.
        • Ohta M.
        • Bastron J.A.
        • Okazaki H.
        • Groover R.V.
        Chronic inflammatory polyradiculoneuropathy.
        Mayo Clin Proc. 1975; 50: 21-37
        • Kleyweg R.P.
        • van der Meché F.G.A.
        • Schmitz P.I.M.
        Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain–Barré syndrome.
        Muscle Nerve. 1991; 14: 1103-1109
        • McCombe P.A.
        • Wilson R.
        • Prentice R.L.
        Results of testing for anti-GM1 antibodies.
        J Clin Neurosci. 2000; 7: 209-212https://doi.org/10.1054/jocn.1999.0217
        • Pender M.P.
        • Csurhes P.A.
        • Wolfe N.P.
        • et al.
        Increased circulating T cell reactivity to GM3 and GQ1b gangliosides in primary progressive multiple sclerosis.
        J Clin Neurosci. 2003; 10: 63-66https://doi.org/10.1016/S0967-5868(02)00270-9
        • Yuki N.
        • Yoshino H.
        • Sato S.
        • Ohno T.
        • Miyatake T.
        An acute axonal form of Guillain–Barré syndrome with antibodies against gangliosides GM1 and GD1b – a case report.
        Rinsho Shinkeigaku. 1990; 30: 989-993
        • Ho T.W.
        • Mishu B.
        • Li C.Y.
        • et al.
        Guillain–Barré syndrome in northern China: relationship to Campylobacter jejuni infection and anti-glycolipid antibodies.
        Brain. 1995; 118: 597-605
        • Rees J.H.
        • Gregson N.A.
        • Hughes R.A.
        Anti-ganglioside GM1 antibodies in Guillain–Barré and their relationship to Campylobacter jejuni infection.
        Ann Neurol. 1995; 38: 809-816
        • Visser L.H.
        • Van der Meche F.G.
        • Van Doorn P.A.
        • et al.
        Guillain–Barré syndrome without sensory loss (acute motor neuropathy). A subgroup with specific clinical, electrodiagnostic and laboratory features. Dutch Guillain–Barré Study Group.
        Brain. 1995; 118: 841-847
        • Alaedini A.
        • Briani C.
        • Wirguin I.
        • Siciliano G.
        • D’Avino C.
        • Latov N.
        Detection of anti-ganglioside antibodies in Guillain–Barré syndrome and its variants by the agglutination assay.
        J Neurol Sci. 2002; 196: 41-44
        • Press R.
        • Mata S.
        • Lolli F.
        • Zhu J.
        • Andersson T.
        • Link H.
        Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain–Barré syndrome.
        J Neurol Sci. 2001; 190: 41-47
        • Kuwabara S.
        • Yuki N.
        • Koga M.
        • et al.
        IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain–Barré syndrome.
        Ann Neurol. 1998; 44: 202-208
        • Ogawa-Goto K.
        • Funamoto N.
        • Abe T.
        • Nagashima K.
        Different ceramide compositions of gangliosides between human motor and sensory nerves.
        J Neurochem. 1990; 55: 1486-1493
        • Vincent M.S.
        • Gumperz J.E.
        • Brenner M.B.
        Understanding the function of CD1-restricted T cells.
        Nat Immunol. 2003; 4: 517-523
        • Shamshiev A.
        • Donda A.
        • Carena I.
        • Mori L.
        • Kappos L.
        • De Libero G.
        Self glycolipids as T-cell autoantigens.
        Eur J Immunol. 1999; 29: 1667-1675https://doi.org/10.1002/(SICI)1521-4141(199905)29:05<1667::AID-IMMU1667>3.0.CO;2-U
        • Shamshiev A.
        • Donda A.
        • Prigozy T.I.
        • et al.
        The alphabeta T cell response to self-glycolipids shows a novel mechanism of CD1b loading and a requirement for complex oligosaccharides.
        Immunity. 2000; 13: 255-264
        • Cooper J.C.
        • Ben Smith A.
        • Savage C.O.
        • Winer J.B.
        Unusual T cell receptor phenotype V gene usage of gamma delta T cells in a line derived from the peripheral nerve of a patient with Guillain–Barré syndrome.
        J Neurol Neurosurg Psychiatry. 2000; 69: 522-524
        • Prendergast M.M.
        • Moran A.P.
        Lipopolysaccharides in the development of the Guillain–Barré and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies.
        J Endotoxin Res. 2000; 6: 341-359
        • Yuki N.
        Infectious origins of, and molecular mimicry in, Guillain–Barré and Fisher syndromes.
        Lancet Infect Dis. 2001; 1: 29-37
        • Yuki N.
        • Yoshino H.
        • Sato S.
        • Miyatake T.
        Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis.
        Neurology. 1990; 40: 1900-1902
        • Kaida K.
        • Kusunoki S.
        • Kamakura K.
        • Motoyoshi K.
        • Kanazawa I.
        Guillain–Barré syndrome with antibody to a ganglioside, N-acetylgalactosaminyl GD1a.
        Brain. 2000; 123: 116-124
        • Kaida K.
        • Kusunoki S.
        • Kamakura K.
        • Motoyoshi K.
        • Kanazawa I.
        Guillain–Barré syndrome with IgM antibody to the ganglioside GalNAc-GD1a.
        J Neuroimmunol. 2001; 113: 260-267
        • Wicklein E.M.
        • Pfeiffer G.
        • Yuki N.
        • Hartard C.
        • Kunze K.
        Prominent sensory ataxia in Guillain–Barré syndrome associated with IgG anti-GD1b antibody.
        J Neurol Sci. 1997; 151: 227-229
        • Pan C.L.
        • Yuki N.
        • Koga M.
        • Chiang M.C.
        • Hsieh S.T.
        Acute sensory ataxic neuropathy associated with monospecific anti-GD1b IgG antibody.
        Neurology. 2001; 57: 1316-1318
        • Susuki K.
        • Yuki N.
        • Hirata K.
        Features of sensory ataxic neuropathy associated with anti-GD1b IgM antibody.
        J Neuroimmunol. 2001; 112: 181-187
        • van den Berg L.H.
        • Lankamp C.L.
        • de Jager A.E.
        • et al.
        Anti-sulphatide antibodies in peripheral neuropathy.
        J Neurol Neurosurg Psychiatry. 1993; 56: 1164-1168
        • Pender M.P.
        • Csurhes P.A.
        • Greer J.M.
        • et al.
        Surges of increased T cell reactivity to an encephalitogenic region of myelin proteolipid protein occur more often in patients with multiple sclerosis than in healthy subjects.
        J Immunol. 2000; 165: 5322-5331
        • Illes Z.
        • Kondo T.
        • Newcombe J.
        • Oka N.
        • Tabira T.
        • Yamamura T.
        Differential expression of NK T cell V alpha 24J alpha Q invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy.
        J Immunol. 2000; 164: 4375-4381
        • Winer J.
        • Hughes S.
        • Cooper J.
        • Ben Smith A.
        • Savage C.
        Gamma delta T cells infiltrating sensory nerve biopsies from patients with inflammatory neuropathy.
        J Neurol. 2002; 249: 616-621
        • Kusunoki S.
        • Shimizu J.
        • Chiba A.
        • Ugawa Y.
        • Hitoshi S.
        • Kanazawa I.
        Experimental sensory neuropathy induced by sensitization with ganglioside GD1b.
        Ann Neurol. 1996; 39: 424-431
        • Yuki N.
        • Yamada M.
        • Koga M.
        • et al.
        Animal model of axonal Guillain–Barré syndrome induced by sensitization with GM1 ganglioside.
        Ann Neurol. 2001; 49: 712-720https://doi.org/10.1002/ana.1012
        • Hitoshi S.
        • Kusunoki S.
        • Murayama S.
        • Tsuji S.
        • Kanazawa I.
        Rabbit experimental sensory ataxic neuropathy: anti-GD1b antibody-mediated trkC downregulation of dorsal root ganglia neurons.
        Neurosci Lett. 1999; 260: 157-160
        • Raschetti R.
        • Maggini M.
        • Popoli P.
        • et al.
        Gangliosides and Guillain–Barré syndrome.
        J Clin Epidemiol. 1995; 48: 1399-1405
        • Heidenreich F.
        • Leifeld L.
        • Jovin T.
        T cell-dependent activity of ganglioside GM1-specific B cells in Guillain–Barré syndrome and multifocal motor neuropathy in vitro.
        J Neuroimmunol. 1994; 49: 97-108
        • Borsellino G.
        • Poccia F.
        • Placido R.
        • et al.
        Phenotypic and functional properties of gamma delta T cells from patients with Guillain–Barré syndrome.
        J Neuroimmunol. 2000; 102: 199-207
        • Fujioka T.
        • Purev E.
        • Kremlev S.G.
        • Ventura E.S.
        • Rostami A.
        Flow cytometric analysis of infiltrating cells in the peripheral nerves in experimental allergic neuritis.
        J Neuroimmunol. 2000; 108: 181-191
        • Galli G.
        • Nuti S.
        • Tavarini S.
        • et al.
        CD1d-restricted help to B cells by human invariant natural killer T lymphocytes.
        J Exp Med. 2003; 197: 1051-1057
        • Cooper J.C.
        • Hughes S.
        • Ben Smith A.
        • Savage C.O.
        • Winer J.B.
        T cell recognition of a non-protein antigen preparation of Campylobacter jejuni in patients with Guillain–Barré syndrome.
        J Neurol Neurosurg Psychiatry. 2002; 72: 13-14
        • Yan W.X.
        • Taylor J.
        • Andrias-Kauba S.
        • Pollard J.D.
        Passive transfer of demyelination by serum or IgG from chronic inflammatory demyelinating polyneuropathy patients.
        Ann Neurol. 2000; 47: 765-775https://doi.org/10.1002/1531-8249(200006)47:6<765::AID-ANA9>3.0.CO;2-8